SUNB (SUNB) Stock Price & Analysis
SUNB (SUNB) rose 2.88% to USD 83.63 as of June 10, 2026 at 02:36 UTC, according to Nexqual real-time market data.
SUNB last closed at USD 81.29; the session ranged USD 81.13–84.48 on volume of 3,886,613 shares. Market capitalization is $34.56B, with a 52-week range of USD 61.03–84.48 (NYQ). Source: Nexqual, June 10, 2026 at 02:36 UTC.
Key Statistics (as of June 10, 2026 at 02:36 UTC)
| Price | USD 83.63 |
|---|---|
| Change | ▲ 2.88% (up) |
| Previous Close | USD 81.29 |
| Open | USD 81.27 |
| Day Range | USD 81.13 – 84.48 |
| 52-Week Range | USD 61.03 – 84.48 |
| Volume | 3,886,613 shares |
| Market Cap | $34.56B |
| Exchange | NYQ |
Technical Analysis (SUNB)
Nexqual's technical model rates SUNB "BUY" based on 5 bullish and 2 bearish signals across 70 daily candles, as of June 10, 2026 at 02:36 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.3 (neutral) |
| vs SMA50 | Above (USD 73.43) |
| MACD | 1.95 (positive) |
Analyst Ratings (SUNB)
Wall Street analysts rate SUNB "Buy" based on 14 analysts, with a mean price target of USD 80.64 (range USD 62–115), per Nexqual as of June 10, 2026 at 02:36 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 80.64 |
| High Target | USD 115 |
| Low Target | USD 62 |
| Buy / Hold / Sell | 8 / 3 / 3 |
Earnings (SUNB)
| EPS Estimate | USD 0.79 |
|---|---|
| Revenue Estimate | $2.64B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-01-31 | USD 0.78 vs est 0.84 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Financials & Fundamentals (SUNB)
| Total Revenue | $10.93B |
|---|---|
| Revenue Growth (YoY) | +2.70% |
| Gross Margin | +94.78% |
| Operating Margin | +18.70% |
| Profit Margin | +12.68% |
| ROE | +18.14% |
| Debt / Equity | 137.45 |
| Current Ratio | 1.02 |
| Total Cash | $39.00M |
| Total Debt | $10.47B |
| Free Cash Flow | $4.05B |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Financial Health Score (SUNB)
Nexqual rates SUNB's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:36 UTC.
| Growth | Weak — Revenue -1% YoY (annual), declining |
|---|---|
| Profitability | Strong — Gross margin 95%, operating 19% |
| Balance Sheet | Mixed — $39M cash vs $10.5B debt |
| Cash Flow | Strong — FCF $4.05B, 38% margin |
| Efficiency | Solid — ROE 18%, ROA 6.7% |
Ownership (SUNB)
| Insider Ownership | +0.30% |
|---|---|
| Institutional Ownership | +80.16% |
| Shares Outstanding | 413.30M |
| Float | 407.65M |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Leadership (SUNB)
SUNB is led by Brendan Christopher Horgan (age 52), CEO & Executive Director, per Nexqual as of June 10, 2026 at 02:36 UTC.
| CEO & Executive Director | Brendan Christopher Horgan (age 52) |
|---|---|
| Chief Financial Officer | Alexander W. Pease (age 53) |
| Chief Operating Officer | John Washburn |
| Executive Vice President of Strategy & Business Development | Brad Lull (age 50) |
| Senior Vice President of Investor Relations & Communications | Kevin J. Powers |
Major Backers & Investors (SUNB)
Notable institutional backers of SUNB include Dodge & Cox Inc., Harris Associates L.P., Abrams Bison Investments, LLC, according to Nexqual as of June 10, 2026 at 02:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Dodge & Cox Inc. | 22.56% |
| Harris Associates L.P. | 4.11% |
| Abrams Bison Investments, LLC | 3.04% |
| Wellington Management | 2.72% |
| Invesco | 2.45% |
| Rothschild & Co Wealth Management Uk Ltd | 2.06% |
| Royal Bank of Canada | 1.73% |
| Principal Financial Group, Inc. | 1.6% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.27% |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ANCTF | Alimentation Couche-Tard Inc. | USD 59.12 | ▼ 0.03% |
| BFFAF | BASF SE | USD 61.5 | ▲ 7.12% |
| DPSTF | Deutsche Post AG | USD 59.5 | ▲ 0% |
| DNBBY | DNB ASA | USD 29.93 | ▼ 0.07% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:36 UTC. This page is informational and not investment advice.